drugset / Trial / NCT05062785
Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants
NaSequentialOpen-labelTreatment
Summary
This study is to determine the safety and tolerability of regular insulin (Humulin R) when given intranasally (as drops in nostrils). Healthy participants will be enrolled to determine the maximum tolerated dose of intranasal insulin.
Timeline
- Start
- 2021-10-04
- Primary completion
- 2022-04-25
- Completion
- 2022-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 0 iu | Intranasal |
| Subject | Insulin | Protein / enzyme biologic | 1000 iu | Intranasal |